FindTrial
Sign In

ED95 and ED50 of intravenous dexmedetomidine in the treatment of shivering during elective cesarean section

ED95 and ED50 of intravenous dexmedetomidine in the treatment of shivering during elective cesarean section

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039264
Enrollment
Unknown
Registered
2020-10-22
Start date
2020-10-19
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

shivering

Interventions

D1:0.2 µg/kg dexmedetomidine
D2:0.25µg/kg dexmedetomidine
D3:0.3 µg/kg dexmedetomidine
D4:0.35 µg/kg dexmedetomidine
D5:0.4 µg/kg dexmedetomidine

Sponsors

Women's Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Implementation of elective cesarean section, full-term singleton maternal.

Exclusion criteria

Exclusion criteria: 1. Pregnant women with history of fetal disease, heart disease, mental illness, drug treatment, recent fever, uncertain anesthetic effect, intraoperative blood transfusion, etc. 2. At the same time, allergy, non elective cesarean section, premature birth, twins and multiple births were excluded.

Design outcomes

Primary

MeasureTime frame
Shivering;HR, Blood pressure;—

Secondary

MeasureTime frame
Age, height, weight, Gestational week, pregnancy;Operation time;Side effects;Nausea and vomit, hypertention, pruritus, bradycardia, hypotention;Temperature;Atropine;Norepinephrine;VAS;Satisfaction;—

Countries

China

Contacts

Public ContactMeijuan Yang

Obstetrics and Gynecology Hospital Affiliated to Zhejiang University Medical College

yangmeijuan@zju.edu.cn+86 15088688422

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026